One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like Silk Road Medical Inc before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell Silk Road Medical Inc’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding Silk Road Medical Inc’s stock price such as:

• Current stock price and volume
• Stock price history
• Upgrades and downgrades from analysts
• Stock price momentum as measured by its relative strength

About Silk Road Medical Inc (SILK)

Before we jump into Silk Road Medical Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Silk Road Medical, Inc. is a medical device company, which is focused on reducing the risk of stroke and its devastating impact. The Company has discovered an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR), which relies on two concepts: minimally invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain and combines the benefits of innovative endovascular techniques with fundamental surgical principles. The Company's ENROUTE Transcarotid Neuroprotection System (NPS) and ENROUTE Transcarotid Stent System are the products for use in TCAR. Its ENROUTE Transcarotid Stent System is placed during a period of temporary high-rate blood flow reversal, which is enabled by its ENROUTE Transcarotid NPS. It markets and sells its products in the United States through a direct sales organization consisting of approximately 64 sales representatives and 62 clinical support specialists.

Want to learn more about Silk Road Medical Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Silk Road Medical Inc. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

Silk Road Medical Inc’s Stock Price as of Market Close

As of February 16, 2023, 4:00 PM CST, Silk Road Medical Inc’s stock price was $52.72.

Silk Road Medical Inc is up 4.79% from its previous closing price of $50.31.

During the last market session, Silk Road Medical Inc’s stock traded between $49.66 and $51.45. Currently, there are 35.30 million shares of Silk Road Medical Inc stock available for purchase.

Unfortunately, Silk Road Medical Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Silk Road Medical Inc Stock Price History

Silk Road Medical Inc’s (SILK) price is currently down 3.02% so far this month.

During the month of February, Silk Road Medical Inc’s stock price has reached a high of $57.96 and a low of $48.11.

Over the last year, Silk Road Medical Inc has hit prices as high as $58.04 and as low as $27.21. Year to date, Silk Road Medical Inc’s stock is up 23.73%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Silk Road Medical Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of February 15, 2023, there was 1 analyst who downgraded Silk Road Medical Inc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Silk Road Medical Inc’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

Silk Road Medical Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Silk Road Medical Inc (SILK) by visiting AAII Stock Evaluator.

Relative Price Strength of Silk Road Medical Inc

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of February 15, 2023, Silk Road Medical Inc has a weighted four-quarter relative price strength of 10.19%, which translates to a Momentum Score of 88 and is considered to be Very Strong.

Want to learn more about how Silk Road Medical Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Silk Road Medical Inc Stock Price: Bottom Line

As of February 16, 2023, Silk Road Medical Inc’s stock price is $52.72, which is up 4.79% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell Silk Road Medical Inc’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.